Nxera Pharma Co., Ltd. (TYO:4565)

Japan · Delayed Price · Currency is JPY

905.00

+54.00 (6.35%)

At close: Mar 6, 2026

Revenue by Segment

Financials in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2018
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Mar '18 Mar 31, 2018
Pharmaceutical Business	29.62B	28.84B	12.77B	15.57B	17.71B
Pharmaceutical Business Growth	2.71%	125.87%	-18.00%	-12.10%	100.32%
Total	29.62B	28.84B	12.77B	15.57B	17.71B
Total Growth	2.71%	125.87%	-18.00%	-12.10%	100.32%

Revenue by Geography

Financials in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2018
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Mar '18 Mar 31, 2018
Japan	17.97B	14.06B	6.17B	80.00M	-22.00M
Japan Growth	27.81%	127.73%	7616.25%	-	-
United States of America	4.89B	7.95B	1.37B	9.93B	13.94B
United States of America Growth	-38.54%	479.02%	-86.18%	-28.72%	350.45%
Switzerland	2.17B	2.19B	4.00B	2.56B	2.31B
Switzerland Growth	-0.96%	-45.30%	56.16%	10.95%	-28.12%
United Kingdom	1.77B	696.00M	4.00M	142.00M	1.18B
United Kingdom Growth	154.74%	17300.00%	-97.18%	-87.95%	-30.95%
Bermuda	1.41B	1.16B	1.21B	2.85B	301.00M
Bermuda Growth	21.12%	-4.29%	-57.46%	846.51%	-36.90%
Germany	1.34B	2.78B	-	-	-
Germany Growth	-51.82%	-	-	-	-
Others	74.00M	-	-	-	-
Ireland	-	-	-	-	7.00M
Ireland Growth	-	-	-	-	-92.55%
Total	29.61B	28.84B	12.77B	15.57B	17.71B
Total Growth	2.70%	125.87%	-18.00%	-12.10%	100.32%

Source: S&P Global Market Intelligence.